Fitness Trends Recombinant DNA Technology Market | Página 3
the desired genes in insect cells and provide high yields of recombinant protein that speeds up
the cloning reaction as compared to the time-consuming restriction enzyme cloning, which takes
2–3 days. Also, in 2016, a BioAg Alliance was formed between Monsanto and Novozymes A/S,
to improve crop harvests by using products containing naturally-occurring microbes to boost
agricultural productivity and expand its product portfolio. However, the adoption of non-
biologic therapeutics and higher complexity of the genetically engineered products such as
stability of the cell lines, requirement of skilled professionals, and optimum temperature are the
factors hindering the market growth.
Major players operating in the global recombinant DNA technology market are Thermo Fisher
Scientific, Inc., Biogen, Inc., Sanofi Pasteur, Merck & Co., Inc., Pfizer, Inc., Profacgen, Amgen,
Inc., and Monsanto Company.
Browse Complete Report For More Information @
https://www.coherentmarketinsights.com/market-insight/recombinant-dna-technology-market-893
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com